Pages that link to "Q102318823"
Jump to navigation
Jump to search
The following pages link to Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial (Q102318823):
Displayed 7 items.
- Age and frailty in COVID-19 vaccine development (Q102318819) (← links)
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK (Q104286457) (← links)
- Oxford-AstraZeneca COVID-19 vaccine efficacy (Q104286460) (← links)
- Viral targets for vaccines against COVID-19 (Q104503058) (← links)
- A Biochemical Perspective of the Nonstructural Proteins (NSPs) and the Spike Protein of SARS CoV-2 (Q106452919) (← links)
- Site-specific steric control of SARS-CoV-2 spike glycosylation (Q110137153) (← links)
- Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation (Q110315017) (← links)